Steven D. Rubin, Director at Entera Bio Ltd. ([ENTX]), bought 10,000 shares at $1.20 ($12K) on 2026-02-09, disclosed to the SEC on 2026-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OPK | BUY | 2024-01-05 | $9K | — | Filing → |
| OPK | BUY | 2023-11-13 | $13K | — | Filing → |
| CDXC | BUY | 2023-05-30 | $10K | — | Filing → |